furazolidone has been researched along with Glycogen Storage Disease in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czarnecki, CM | 2 |
Jegers, A | 1 |
Jankus, EF | 2 |
Salam, A | 1 |
Caldwell, R | 1 |
2 other studies available for furazolidone and Glycogen Storage Disease
Article | Year |
---|---|
Characterization of glycogen in selected tissues of turkey poults with spontaneous round heart disease and furazolidone-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Furazolidone; Glucose; Glycogen; Glycogen Storage Disease; Glycogen Stora | 1978 |
Activity of alpha-1, 4-glucosidase in furazolidone-induced glycogenosis.
Topics: alpha-Glucosidases; Animals; Furazolidone; Glucosidases; Glycogen Storage Disease; Liver; Male; Poul | 1978 |